Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2J2 | P51589 | 12/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 6/20 | 0.48 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9874170 | 0.97 | MEN1 (0.49) | CYP2J2CYP3A4CYP2C9CYP2B6MEN1 | |
| SCHEMBL9874399 | 0.94 | ALDH1A1 (0.48) | CYP2J2CYP3A4CYP2C9CYP2B6MEN1 | |
| SCHEMBL9874149 | 0.87 | CYP2J2 (0.61) | CYP2J2CYP3A4CYP2C9CYP2B6HRH1 | |
| SCHEMBL9874649 | 0.87 | CYP2J2 (0.54) | CYP2J2CYP3A4CYP2C9CYP2B6MEN1 | |
| SCHEMBL9872567 | 0.87 | CYP2J2 (0.67) | CYP2J2CYP3A4CYP2C9CYP2B6HRH1 | |
| SCHEMBL9874097 | 0.86 | CYP2J2 (0.49) | CYP2J2CYP3A4CYP2C9CYP2B6MEN1 | |
| SCHEMBL9871663 | 0.85 | CYP2J2 (0.52) | CYP2J2CYP3A4CYP2C9CYP2B6MEN1 | |
| SCHEMBL9871858 | 0.84 | CYP2J2 (0.58) | CYP2J2CYP3A4CYP2C9CYP2B6HRH1 | |
| SCHEMBL9874017 | 0.84 | CYP2J2 (0.51) | CYP2J2CYP3A4CYP2C9CYP2B6HRH1 | |
| SCHEMBL9872364 | 0.83 | CYP2J2 (0.62) | CYP2J2CYP3A4CYP2C9CYP2B6HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5057524-A | Asthma, dermatitis | A. H. ROBINS COMPANY INCORPORATED (US) | 1991-10-15 | — | — | US | disclosed |